PubRank
Search
About
Plasma Cytochrome c as Biomarker of Traumatic Injury and Predictor of Outcome
Clinical Trial ID NCT02440373
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT02440373
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.
Intensive Care Med
1996
35.00
2
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.
Cell
1997
24.57
3
Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome.
Crit Care Med
1995
10.29
4
Biochemical pathways of caspase activation during apoptosis.
Annu Rev Cell Dev Biol
1999
8.21
5
An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9.
J Biol Chem
1999
6.88
6
Emergency medical services intervals and survival in trauma: assessment of the "golden hour" in a North American prospective cohort.
Ann Emerg Med
2009
3.92
7
A descriptive analysis of Emergency Medical Service Systems participating in the Resuscitation Outcomes Consortium (ROC) network.
Prehosp Emerg Care
2007
3.90
8
Cytochrome c release from mitochondria proceeds by a two-step process.
Proc Natl Acad Sci U S A
2002
3.57
9
Cytochrome c: functions beyond respiration.
Nat Rev Mol Cell Biol
2008
2.95
10
Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial.
Ann Surg
2011
2.85
11
Epidemiology and outcomes from out-of-hospital cardiac arrest in children: the Resuscitation Outcomes Consortium Epistry-Cardiac Arrest.
Circulation
2009
2.49
12
Comparison of multiple organ dysfunction scores in the prediction of hospital mortality in the critically ill.
Crit Care Med
2002
2.47
13
Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy.
Proc Natl Acad Sci U S A
1999
2.42
14
The design and interpretation of pilot trials in clinical research in critical care.
Crit Care Med
2009
2.38
15
Functional consequences of caspase activation in cardiac myocytes.
Proc Natl Acad Sci U S A
2002
1.98
16
Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation.
J Biol Chem
1999
1.96
17
Multiple organ dysfunction: baseline and serial component scores.
Crit Care Med
2001
1.88
18
Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis.
Circulation
1999
1.74
19
Impact of prehospital mode of transport after severe injury: a multicenter evaluation from the Resuscitation Outcomes Consortium.
J Trauma Acute Care Surg
2012
1.71
20
The Multiple Organ Dysfunction Score (MODS) versus the Sequential Organ Failure Assessment (SOFA) score in outcome prediction.
Intensive Care Med
2002
1.71
21
Multiple organ failure in trauma patients.
J Trauma
2003
1.66
22
Zoniporide preserves left ventricular compliance during ventricular fibrillation and minimizes postresuscitation myocardial dysfunction through benefits on energy metabolism.
Crit Care Med
2007
1.66
23
The Multiple Organ Dysfunction Score as a descriptor of patient outcome in septic shock compared with two other scoring systems.
Crit Care Med
1999
1.50
24
Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion.
Biochim Biophys Acta
2010
1.35
25
Circulating levels of cytochrome c after resuscitation from cardiac arrest: a marker of mitochondrial injury and predictor of survival.
Am J Physiol Heart Circ Physiol
2006
1.22
26
Cytochrome c: occurrence and functions.
Chem Rev
2006
1.21
27
Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy.
Int J Cancer
2005
1.17
28
Ca2+-induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: role of cardiolipin.
J Biol Chem
2004
1.15
29
Cytochrome c and tumor necrosis factor-alpha values in serum and cerebrospinal fluid of patients with influenza-associated encephalopathy.
Pediatr Infect Dis J
2005
1.11
30
Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes.
J Mol Cell Cardiol
2000
1.09
31
Cytochrome c biogenesis in mitochondria.
Mitochondrion
2007
1.06
32
Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes.
Cardiol Clin
2001
0.98
33
Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of fluid resuscitation versus improved outcome after vasopressin.
Anesth Analg
2004
0.95
34
Serum cytochrome c level as a prognostic indicator in patients with systemic inflammatory response syndrome.
Clin Chim Acta
2004
0.94
35
Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion.
Life Sci
2005
0.93
36
Prognostic predictive values of serum cytochrome c, cytokines, and other laboratory measurements in acute encephalopathy with multiple organ failure.
Arch Dis Child
2006
0.93
37
Evidence for early supply independent mitochondrial dysfunction in patients developing multiple organ failure after trauma.
J Trauma
1997
0.92
38
Proximal tubular cytochrome c efflux: determinant, and potential marker, of mitochondrial injury.
Kidney Int
2004
0.91
39
Arginine vasopressin: the future of pressure-support resuscitation in hemorrhagic shock.
J Surg Res
2012
0.89
40
Steady as a ROC: the Resuscitation Outcomes Consortium.
Resuscitation
2008
0.88
41
Vasopressin for hemorrhagic shock management: revisiting the potential value in civilian and combat casualty care.
J Trauma
2010
0.86
42
Protecting mitochondrial bioenergetic function during resuscitation from cardiac arrest.
Crit Care Clin
2012
0.85
43
Cytochrome c is a possible new marker for fulminant hepatitis in humans.
J Gastroenterol
2005
0.84
44
Circulating cytochrome c as potential biomarker of impaired reperfusion in ST-segment elevation acute myocardial infarction.
Am J Cardiol
2010
0.83
45
Cytochrome-c detection: a diagnostic marker for myocardial infarction.
Appl Biochem Biotechnol
2001
0.82
46
AVE4454B--a novel sodium-hydrogen exchanger isoform-1 inhibitor--compared less effective than cariporide for resuscitation from cardiac arrest.
Transl Res
2010
0.80
47
Cytochrome c is rapidly extruded from apoptotic cells and detectable in serum of anticancer-drug treated tumor patients.
Adv Exp Med Biol
2001
0.79
48
Activation of caspase-3 may not contribute to postresuscitation myocardial dysfunction.
Am J Physiol Heart Circ Physiol
2009
0.78
49
Serum cytochrome c to indicate the extent of ongoing tumor cell death.
Int J Lab Hematol
2008
0.77
50
Serum cytochrome c detection using a cytochrome c oxidase biosensor.
Biotechnol Appl Biochem
2007
0.75
51
Determination of cytochrome c in human serum and pharmaceutical injections using flow injection chemiluminescence.
Appl Biochem Biotechnol
2009
0.75
52
Disposable biosensor based on Au nanoparticles-modified CdS nanorod arrays for detection cytochrome c.
J Nanosci Nanotechnol
2011
0.75
Next 100